Telmisartan And Amlodipine
Product Images NDC 68180-199

13 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Telmisartan And Amlodipine (NDC 68180-199). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 01

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 01
A line graph showing the percentage of patients with systolic blood pressure under 140 mmHg plotted against baseline systolic blood pressure (SBP) in mmHg. The graph compares four treatments: Telmisartan 80 mg / Amlodipine 10 mg, Telmisartan 80 mg, Amlodipine 10 mg, and placebo, each represented by different symbols and lines.*
FDA Label Image

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 02

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 02
A line graph depicting the percentage of patients achieving systolic blood pressure (SBP) below 130 mmHg relative to baseline SBP (mmHg). The graph compares four treatments: T80/A10, T80, A10, and Placebo, showing their efficacy trends over baseline SBP values from 140 to 180 mmHg for Telmisartan and Amlodipine.*
FDA Label Image

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 03

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 03
Line graph showing the percentage of patients with diastolic blood pressure (DBP) over 90 mmHg relative to baseline DBP (mmHg). It compares the effectiveness of four treatments: a combination of Telmisartan 80 mg and Amlodipine 10 mg (T80/A10), Telmisartan 80 mg alone (T80), Amlodipine 10 mg alone (A10), and a placebo. The graph indicates that the combination therapy maintains a higher percentage of patients with DBP above 90 mmHg across baseline values compared to individual treatments and placebo.*
FDA Label Image

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 04

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 04
A line graph depicting the percentage of patients with diastolic blood pressure (DBP) below 80 mmHg based on baseline DBP values ranging from 95 to 110 mmHg. The graph compares four treatment groups: T80/A10 (Telmisartan 80 mg with Amlodipine 10 mg), T80 (Telmisartan 80 mg), A10 (Amlodipine 10 mg), and Placebo. Percentage on the y-axis decreases as baseline DBP increases on the x-axis, with T80/A10 showing the highest percentage response and placebo the lowest.*
FDA Label Image

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 05

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 05
Chemical structure diagram of the active ingredient Telmisartan, showing its molecular components and bonds as part of the Telmisartan and Amlodipine drug product by Lupin Pharmaceuticals, Inc.*
FDA Label Image

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 06

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 06
Chemical structure of the active ingredient Amlodipine, part of the pharmaceutical product Telmisartan and Amlodipine, illustrating its molecular configuration with associated functional groups.*
FDA Label Image

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 07

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 07
An instructional illustration showing a hand peeling back the foil from a blister pack containing rectangular tablets in two columns. The image depicts the proper way to separate and push out individual tablets from the blister pack.*
FDA Label Image

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 08

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 08
An instructional illustration showing hands peeling open a foil pouch labeled Telmisartan and Amlodipine 80 mg 15 mg, demonstrating how to open the medication packaging.*
FDA Label Image

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 09

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 09
A black-and-white instructional illustration showing two hands opening a blister pack to remove a single round tablet. The finger pressing down on the tablet with a downward arrow indicates the method to push the tablet through the foil backing.*
FDA Label Image

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 10

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 10
Packaging label for Telmisartan and Amlodipine Tablets USP, 40 mg/5 mg strength, containing 30 tablets. Label shows dosage instructions, storage conditions, and warnings. Manufactured for Lupin Pharmaceuticals, Inc., with manufacturing by Lupin Limited in Goa, India. The label includes an NDC code and bar code.*
FDA Label Image

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 11

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 11
Label for Telmisartan and Amlodipine Tablets USP 40 mg/10 mg by Lupin Pharmaceuticals, Inc. The label indicates a package size of 30 tablets and provides storage instructions, dosage referral, and manufacturing details including Lupin Limited in India.*
FDA Label Image

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 12

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 12
Label for Telmisartan and Amlodipine Tablets USP, 80 mg/5 mg strength, containing 30 tablets. The label includes storage instructions, dosage reference, manufacturer details (Lupin Pharmaceuticals, Inc. and Lupin Limited), and warnings to protect from moisture and light. The product is marked Rx only and indicates dispensing with a patient information leaflet.*
FDA Label Image

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 13

Db056024 A5b4 4f2a 8fe0 8ee308cf5700 13
Label for Telmisartan and Amlodipine Tablets USP 80 mg/10 mg, packaging with 30 tablets. The label includes usage instructions for pharmacists, storage conditions, and manufacturing information by Lupin Pharmaceuticals, Inc., Baltimore, Maryland and Lupin Limited, Goa, India. The label emphasizes dispensing with patient information leaflets and protection from moisture and light.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.